GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » Forward PE Ratio

Tatva Chintan Pharma Chem (BOM:543321) Forward PE Ratio : 33.21 (As of Dec. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Forward PE Ratio?

Tatva Chintan Pharma Chem's Forward PE Ratio for today is 33.21.

Tatva Chintan Pharma Chem's PE Ratio without NRI for today is 117.86.

Tatva Chintan Pharma Chem's PE Ratio (TTM) for today is 118.33.


Tatva Chintan Pharma Chem Forward PE Ratio Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Forward PE Ratio Chart

Tatva Chintan Pharma Chem Annual Data
Trend 2024-12
Forward PE Ratio
33.21

Tatva Chintan Pharma Chem Quarterly Data
2024-12
Forward PE Ratio 33.21

Competitive Comparison of Tatva Chintan Pharma Chem's Forward PE Ratio

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's Forward PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's Forward PE Ratio falls into.



Tatva Chintan Pharma Chem Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Tatva Chintan Pharma Chem  (BOM:543321) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Tatva Chintan Pharma Chem Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem Headlines

No Headlines